Skip to main content
Top
Published in: Supportive Care in Cancer 3/2012

01-03-2012 | Editorial

“Important difference” for interpreting health-related quality of life outcome measures: important to whom?

Author: Jackson S. Y. Wu

Published in: Supportive Care in Cancer | Issue 3/2012

Login to get access

Excerpt

In a hospital-based cancer clinic, a typical visit of an advanced cancer patient might start with this exchange: “Mrs. J, how are you doing?” “Well, I have been better…” “What’s bothering you the most these days?” “I feel nauseated all the time…I can’t do anything any more.” The clinician then evaluates the acuity and severity of the symptom, but also considers the whereabouts of the patient on her disease trajectory, whether her current combination therapy should be delayed, changed or stopped; whether opioid should be rotated, or steroid added, or new antiemetic, etc. Very quickly a complicated plan of management emerges, but one important thought the patient wishes to tell someone is lost in the shuffle, “I don’t like being so dependent on others; I’m a burden to my family…I have no energy for anything or anyone.” …
Literature
1.
go back to reference Kassa S, Loge JH (2003) Quality of life in palliative care: principles and practice. Pall Med 17:11–20CrossRef Kassa S, Loge JH (2003) Quality of life in palliative care: principles and practice. Pall Med 17:11–20CrossRef
2.
go back to reference Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376PubMedCrossRef
3.
go back to reference Kirshner B, Guyatt GH (1985) A methodological framework for assessing health indices. J Chron DIs 38(1):27–36PubMedCrossRef Kirshner B, Guyatt GH (1985) A methodological framework for assessing health indices. J Chron DIs 38(1):27–36PubMedCrossRef
4.
go back to reference Streiner DL, Norman GR (2003) Health measurement scales: a practice guide to their development and use, 3rd edn. Oxford University Press, Oxford Streiner DL, Norman GR (2003) Health measurement scales: a practice guide to their development and use, 3rd edn. Oxford University Press, Oxford
5.
go back to reference Schunemann HJ, Guyatt GH (2005) Commentary—goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res 40:593–596PubMedCrossRef Schunemann HJ, Guyatt GH (2005) Commentary—goodbye M(C)ID! Hello MID, where do you come from? Health Serv Res 40:593–596PubMedCrossRef
6.
go back to reference Dworkin RH, Turk DC, Wyrwich W, Beaton D, Cleeland CS, Farrar JT et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9(2):105–121PubMedCrossRef Dworkin RH, Turk DC, Wyrwich W, Beaton D, Cleeland CS, Farrar JT et al (2008) Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9(2):105–121PubMedCrossRef
7.
go back to reference Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epi 61:102–109CrossRef Revicki D, Hays RD, Cella D, Sloan J (2008) Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. J Clin Epi 61:102–109CrossRef
8.
go back to reference Beaton DE, Bombardier C, Katz JN, Wright JG (2001) A taxonomy of responsiveness. J Clin Epi 54:1204–1217CrossRef Beaton DE, Bombardier C, Katz JN, Wright JG (2001) A taxonomy of responsiveness. J Clin Epi 54:1204–1217CrossRef
9.
go back to reference Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12–19PubMedCrossRef Jacobson NS, Truax P (1991) Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59:12–19PubMedCrossRef
10.
go back to reference Hageman WJJ, Arrindell WA (1999) Establishing clinically significant change: increment of precision and the distinction between individual and group level of analysis. Behav Res Ther 37:1169–1193PubMedCrossRef Hageman WJJ, Arrindell WA (1999) Establishing clinically significant change: increment of precision and the distinction between individual and group level of analysis. Behav Res Ther 37:1169–1193PubMedCrossRef
11.
go back to reference Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C et al (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 19(11):1753–1760PubMedCrossRef Maringwa JT, Quinten C, King M, Ringash J, Osoba D, Coens C et al (2011) Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Support Care Cancer 19(11):1753–1760PubMedCrossRef
12.
go back to reference Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed
13.
go back to reference Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small cell lung cancer. N Engl J Med 363:733–742PubMedCrossRef
14.
go back to reference Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C et al (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865–871PubMedCrossRef Quinten C, Coens C, Mauer M, Comte S, Sprangers MAG, Cleeland C et al (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10:865–871PubMedCrossRef
Metadata
Title
“Important difference” for interpreting health-related quality of life outcome measures: important to whom?
Author
Jackson S. Y. Wu
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 3/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-011-1350-2

Other articles of this Issue 3/2012

Supportive Care in Cancer 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine